XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 1,133,649 $ 1,033,670 $ 3,263,201 $ 3,077,995
Cost of revenue 555,020 517,351 1,584,686 1,565,231
Gross profit 578,629 516,319 1,678,515 1,512,764
Operating expenses:        
Research and development 260,903 241,654 756,170 707,145
Sales and marketing 212,576 262,898 644,150 784,383
General and administrative 106,350 114,071 332,300 361,491
Restructuring costs 3,694 3,437 13,330 140,281
Impairment of long-lived assets 0 3,162 0 34,278
Total operating expenses 583,523 625,222 1,745,950 2,027,578
Loss from operations (4,894) (108,903) (67,435) (514,814)
Other income (expenses), net:        
Share of losses from equity method investment (25,279) (31,058) (78,794) (93,838)
Impairment of strategic investments (803) 0 (1,470) (46,154)
Other income, net 27,325 1 72,644 17,731
Total other income (expenses), net 1,243 (31,057) (7,620) (122,261)
Loss before provision for income taxes (3,651) (139,960) (75,055) (637,075)
Provision for income taxes (6,075) (1,747) (21,878) (12,958)
Net loss attributable to common stockholders $ (9,726) $ (141,707) $ (96,933) $ (650,033)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.06) $ (0.78) $ (0.57) $ (3.54)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.06) $ (0.78) $ (0.57) $ (3.54)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 159,091,110 181,749,309 170,063,452 183,854,526
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 159,091,110 181,749,309 170,063,452 183,854,526